Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Jul 21, 2010; 16(27): 3457-3464
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3457
Table 1 Contents of included studies
AuthorLocationImmunosuppressionNumber of patientsContents
Meyer et al[9]FranceCyclosporine, methylpred- nisolone and azathioprine162HLA-A, B and DR (5-yr graft survival); HLA-DR (1- and 5-yr graft survival)
Jakab et al[10]AmericanNS631HLA-A, B and DR (1- and 5-yr graft survival); HLA-A and HLA-B (5-yr graft survival)
Neumanna et al[8]GermanyCyclosporine, azathioprine and prednisolone836HLA-A, B and DR (1- and 5-yr graft survival and rejection); HLA-A and HLA-DR (1- and 5-yr graft survival); HLA-B (1-yr graft survival)
Hashimoto et al[11]JapanCyclosporine, methylpred- nisolone and azathioprine50HLA-A, B and DR (1- and 5-yr graft survival)
Langrehr et al[12]GermanyCyclosporine, azathioprine and prednisolone165HLA-A, B and DR (1- and 5-yr graft survival and rejection)
Suehiro et al[13]JapanTacrolimus and Steroids104HLA-A, B and DR (1- and 5-yr graft survival and rejection)
Harihara et al[14]JapanTacrolimus and Steroids85HLA-A, B and DR (rejection)
Balan et al[7]AmericanCyclosporine, prednisone, and azathioprine or tacrolimus799HLA-A, B and DR (1- and 5-yr graft survival); HLA-A (5-yr graft survival)
Sugawara et al[16]JapanTacrolimus and methyl- prednisolone113HLA-DR (1-yr graft survival)
Doran et al[22]GermanyNS446HLA-A, B and DR (1- yr graft survival); HLA-A and HLA-B (1-yr graft survival)
Poli et al[15]ItalyCyclosporine, azathioprine and tacrolimus814HLA-DR (5-yr graft survival)
Yagihashi et al[18]AmericanCyclosporine, azathioprine and tacrolimus347HLA-A, HLA-B and HLA-DR (1-yr graft survival)
Nikaein et al[21]AmericanCyclosporine and prednisone701HLA-A, B and DR (1-yr graft survival); HLA-A (1- and 5-yr graft survival); HLA-B and HLA-DR (1-yr graft survival)
Markus et al[20]AmericanNS527HLA-A (5-yr graft survival); HLA-DR (1-yr graft survival)
Donaldson et al[19]BritainCyclosporine, azathioprine466HLA-A, B and DR (1-yr graft survival and rejection); HLA-A and HLA-B (1-yr graft survival)
Knechtle et al[17]AmericanNS324HLA-A, B and DR (1-yr graft survival); HLA-A, HLA-B and HLA-DR (1-yr graft survival)